No further details were included in this feed item.
Edgewise Therapeutics CEO Kevin Koch sells $785,042 in stock
Shown as published in the source's RSS feed — the text above is everything the feed itself carried. Follow the source link for the complete article on the publisher's own site; it opens in a new tab.